Cargando…

Towards accurate (177)Lu SPECT activity quantification and standardization using lesion-to-background voxel ratio

BACKGROUND: Conventional calibration of the gamma camera consists of the calculation of calibration factors (CFs) (ratio of counts/cc and true concentration activity) as the function of the volume of interest (VOI). However, such method shows inconsistent results when the background activity varies....

Descripción completa

Detalles Bibliográficos
Autores principales:	Raskin, Stanislav, Gamliel, Dan, Abookasis, David, Ben-Haim, Simona, Chicheportiche, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871126/ https://www.ncbi.nlm.nih.gov/pubmed/36689080 http://dx.doi.org/10.1186/s40658-023-00526-x

Ejemplares similares

Accuracy of (177)Lu activity quantification in SPECT imaging: a phantom study
por: Uribe, Carlos F., et al.
Publicado: (2017)

In vivo quantification of (177)Lu with planar whole-body and SPECT/CT gamma camera imaging
por: Bailey, Dale L., et al.
Publicado: (2015)

Quantitative accuracy of (177)Lu SPECT imaging for molecular radiotherapy
por: Mezzenga, Emilio, et al.
Publicado: (2017)

Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
por: Beauregard, Jean-Mathieu, et al.
Publicado: (2011)

The effect of calibration factors and recovery coefficients on (177)Lu SPECT activity quantification accuracy: a Monte Carlo study
por: Ramonaheng, Keamogetswe, et al.
Publicado: (2021)

Intraindividual comparison of [(177)Lu]Lu-DOTA-EB-TATE and [(177)Lu]Lu-DOTA-TOC
por: Hänscheid, Heribert, et al.
Publicado: (2021)

Comprehensive SPECT/CT system characterization and calibration for (177)Lu quantitative SPECT (QSPECT) with dead-time correction
por: Frezza, Andrea, et al.
Publicado: (2020)

Deadtime effects in quantification of (177)Lu activity for radionuclide therapy
por: Uribe, Carlos F., et al.
Publicado: (2018)

Predictive power of the post-treatment scans after the initial or first two courses of [(177)Lu]-DOTA-TATE
por: Chicheportiche, Alexandre, et al.
Publicado: (2018)

Improving quantitative dosimetry in (177)Lu-DOTATATE SPECT by energy window-based scatter corrections
por: de Nijs, Robin, et al.
Publicado: (2014)

Impact of dead time on quantitative (177)Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
por: Desy, Alessandro, et al.
Publicado: (2020)

Reconstructed SPECT images of (177)Lu homogeneous cylindrical phantom used for calibration and texture analysis
por: Mezzenga, Emilio, et al.
Publicado: (2022)

Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT/CT systems
por: Peters, Steffie M. B., et al.
Publicado: (2020)

Quantitative accuracy of (177)Lu SPECT reconstruction using different compensation methods: phantom and patient studies
por: Hippeläinen, Eero, et al.
Publicado: (2016)

SPECT image segmentation for estimation of tumour volume and activity concentration in (177)Lu-DOTATATE radionuclide therapy
por: Gustafsson, Johan, et al.
Publicado: (2017)

Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points
por: Chen, Gefei, et al.
Publicado: (2023)

Practical kidney dosimetry in peptide receptor radionuclide therapy using [(177)Lu]Lu-DOTATOC and [(177)Lu]Lu-DOTATATE with focus on uncertainty estimates
por: Staanum, Peter Frøhlich, et al.
Publicado: (2021)

First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [(177)Lu]Lu-DOTA.SA.FAPi and [(177)Lu]Lu-DOTAGA.(SA.FAPi)(2)
por: Ballal, Sanjana, et al.
Publicado: (2021)

Matched-pair analysis of [(177)Lu]Lu-PSMA I&T and [(177)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
por: Hartrampf, Philipp E., et al.
Publicado: (2022)

Kidney absorbed radiation doses for [(177)Lu]Lu-PSMA-617 and [(177)Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry
por: Uijen, Maike J.M., et al.
Publicado: (2023)

Accuracy of two dosimetry software programs for (177)Lu radiopharmaceutical therapy using voxel-based patient-specific phantoms
por: Ramonaheng, Keamogetswe, et al.
Publicado: (2022)

Evaluation of the (177m)Lu-concentration in in-house produced (177)Lu-radiopharmaceuticals and commercially available Lutathera(®)
por: Balzer, Matthias, et al.
Publicado: (2023)

Correction to: Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT/CT systems
por: Peters, Steffie M. B., et al.
Publicado: (2021)

Influence of sampling schedules on [(177)Lu]Lu-PSMA dosimetry
por: Rinscheid, Andreas, et al.
Publicado: (2020)

Extravasation of [(177)Lu]Lu-DOTATOC: case report and discussion
por: Arveschoug, Anne Kirstine, et al.
Publicado: (2020)

Improved quality control of [(177)Lu]Lu-PSMA I&T
por: Kraihammer, Martin, et al.
Publicado: (2023)

Urinary excretion kinetics of [(177)Lu]Lu-PSMA-617
por: de Bakker, Maarten, et al.
Publicado: (2023)

Fast GPU-based Monte Carlo code for SPECT/CT reconstructions generates improved (177)Lu images
por: Rydén, T., et al.
Publicado: (2018)

Texture analysis in (177)Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture features
por: Sarnelli, Anna, et al.
Publicado: (2019)

Simultaneous Visualization of (161)Tb- and (177)Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
por: Borgna, Francesca, et al.
Publicado: (2021)

Impact of the dead-time correction method on quantitative (177)Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy
por: Desy, Alessandro, et al.
Publicado: (2022)

Tumor dosimetry using (177)Lu: influence of background activity, measurement method and reconstruction algorithm
por: Staanum, Peter Frøhlich
Publicado: (2023)

Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy
por: Marin, Gwennaëlle, et al.
Publicado: (2017)

Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats
por: Yousefnia, Hassan, et al.
Publicado: (2015)

Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [(177)Lu]Lu-OPS201 Compared to the Agonist [(177)Lu]Lu-DOTA-TATE
por: Mansi, Rosalba, et al.
Publicado: (2021)

Biodistribution and dosimetry for combined [(177)Lu]Lu-PSMA-I&T/[(225)Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
por: Delker, Astrid, et al.
Publicado: (2023)

Quantitative (177)Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
por: Danieli, Rachele, et al.
Publicado: (2023)

Radionuclide generator-based production of therapeutic (177)Lu from its long-lived isomer (177m)Lu
por: Bhardwaj, Rupali, et al.
Publicado: (2019)

Development of (177)Lu-phytate Complex for Radiosynovectomy
por: Yousefnia, Hassan, et al.
Publicado: (2013)

Lutetium Lu-177 Dotatate Flare Reaction
por: Salner, Andrew L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qhp3k2mdbureqm3tevk6q76ck7